GlassScriptPhysician profile
Sajid Asim Ali
NPI 1750693248
$36,056.01
in general payments reported to CMS, 2019-2025
64 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,773 · 2020: $6,750 · 2021: $3,369 · 2022: $4,370 · 2023: $7,639 · 2024: $4,499 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,242 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Consulting Fee: $3,000 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,242.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Consulting Fee | $3,000.00 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,324.50 | 2019-2024 | Coroflow, Agilis Hispro, Advisor |
| Cardinal Health 200 LLC | $4,317.10 | 2019-2020 | |
| Medtronic Vascular, INC. | $1,769.61 | 2019-2020 | |
| Cardiovascular Systems INC. | $1,440.43 | 2019-2022 | |
| Boston Scientific Corporation | $1,173.74 | 2019-2025 | Watchman Flx, Avvigo Guidance System, General - Therapies |
| Philips North America LLC | $1,078.85 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $1,007.81 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $853.84 | 2019-2025 | |
| Abiomed | $705.61 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.22 | 2019-2025 | Jardiance |
| Amgen INC. | $598.21 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $477.45 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $410.05 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Angiodynamics, INC. | $383.01 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $371.34 | 2020-2025 | Farxiga |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $362.94 | 2019-2025 | Opsynvi, Opsumit, Uptravi |
| Arbor Pharmaceuticals, INC. | $358.06 | 2019-2022 | |
| Baxter Healthcare | $356.74 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $291.02 | 2021-2025 | Ozempic, Rybelsus |
| Ablative Solutions, INC. | $289.05 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $279.73 | 2020-2025 | Camzyos |
| Medtronic, INC. | $256.45 | 2023-2024 | Onyx Frontier, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.54 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $204.27 | 2019-2022 | |
| Esperion Therapeutics, INC. | $203.27 | 2020-2025 | Nexletol |
| Akcea Therapeutics, INC. | $200.02 | 2019-2021 | |
| Cleerly, INC. | $185.70 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Impulse Dynamics (USA) INC. | $171.39 | 2022 | |
| Bard Peripheral Vascular, INC. | $163.41 | 2019 | |
| Biotronik INC. | $160.33 | 2020 | |
| Lundbeck LLC | $143.80 | 2019-2021 | |
| Bardy Diagnostics, INC. | $140.00 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $119.81 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $97.93 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $93.30 | 2023-2024 | Inpefa |
| Teleflex LLC | $87.74 | 2019 | |
| Astellas Pharma US INC | $75.98 | 2019-2024 | Veozah |
| Endologix LLC | $75.97 | 2019-2021 | |
| Pfizer INC. | $72.31 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.02 | 2025 | |
| Scpharmaceuticals INC. | $64.00 | 2023-2025 | |
| Edwards Lifesciences Corporation | $59.81 | 2022-2025 | Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $58.20 | 2019 | |
| Cardiva Medical, INC. | $57.54 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Azurity Pharmaceuticals, INC. | $54.12 | 2023-2024 | Edarbi, Edarbi |
| Surmodics, INC. | $49.52 | 2022 | |
| Kestra Medical Technology Services, INC. | $46.29 | 2024-2025 | Assure Wcd |
| Althera Pharmaceuticals LLC | $43.45 | 2021 | |
| Veryan Medical Incorporated | $41.89 | 2022 | |
| Gilead Sciences, INC. | $35.93 | 2019 | |
| Becton, Dickinson and Company | $31.52 | 2025 | Lutonix Drug Coated Balloon |
| Bolton Medical INC | $30.42 | 2023 | Treo Abdominal Stent-Graft System |
| Innovation Technologies INC | $29.00 | 2023 | Irrisept |
| Irhythm Technologies, INC. | $25.19 | 2023 | Zio Xt Patch |
| Tactile Systems Technology INC | $21.61 | 2025 | Flexitouch Plus, Nimbl |
| Cashflow Solutions, LLC | $20.75 | 2022 | |
| Mayne Pharma Commercial LLC | $20.54 | 2022 | |
| Medicomp INC | $19.19 | 2021 | |
| Agepha Pharma Fz LLC | $18.23 | 2024 | Lodoco |
| Siemens Medical Solutions USA, INC. | $16.50 | 2022 | |
| Lilly USA, LLC | $15.74 | 2022 | |
| Myocardial Solutions, INC. | $15.06 | 2021 | |
| Venclose INC. | $14.03 | 2019 | |
| Genzyme Corporation | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajid Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.